Dortmund, Germany, March 17, 2026 – iDEL Therapeutics today announced the closing of a EUR 9 million seed financing, establishing its operations and leadership team. The company is pioneering a pipeline of cancer therapeutics that are delivered directly into the...
Essen, 10 February 2025 – Nele Janßen has joined Gründerfonds Ruhr (Ruhrgründer Management GmbH) as an Investment Analyst (working student/part-time), further strengthening the team as the second generation of Gründerfonds Ruhr gains significant momentum. Startup...
